Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV. In December 2006, its developer, GlaxoSmithKline…
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.
In December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.
See also Darunavir TMC-310911
References
Gebaseerd op: Wikipedia — Brecanavir · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.